Metformin-associated lactic acidosis —is this on your radar?
Background: Metformin is a biguanide hyperglycemic agent used to manage non –insulin-dependent diabetes mellitus. Adverse reactions include mainly mild gastrointestinal adverse effects, but severe complications, such as metformin-associated lactic acidosis (MALA) can occur. Metformin is excreted renally and, therefore, not recommended in patients with renal impairment. Th e reported incidence of MALA is 3 cases per 100,000 patient-years. Case Report: A 79-year-old woman with a complex medical history, including end-stage renal disease on dialysis and type 2 diabetes, presented to the emergency department (ED) for altered mental status.
Source: The Journal of Emergency Medicine - Category: Emergency Medicine Authors: Erin L. Simon, Alexandra C. Sherry, Jeffrey Rabinowitz Tags: Clinical Communications: Adult Source Type: research
More News: Diabetes | Diabetes Mellitus | Diabetes Type 2 | Dialysis | Emergency Medicine | Endocrinology | Fortamet | Gastroenterology | Insulin | Men | Metformin